Digital Why AI sovereignty is becoming a requirement for businesses The companies that will lead in this next phase are those that treat AI as an integrated part of their operational architecture.
Digital 5 cybersecurity guidelines for remote monitoring in clinical... Remote monitoring has many advantages in clinical trials.
R&D Connected customer data: a golden opportunity for pharma mar... Data is transforming life sciences, but many organisations are not using its full potential.
Sales & Marketing 7 commercial, sales, and marketing predictions for 2023 In 2022, life sciences companies have been hard at work breaking down silos to better serve patients and healthcare professionals (HCPs).
News Ipsen charts $1.75bn course for Kartos acquisition Ipsen has agreed to buy cancer biotech Kartos Therapeutics for $450m upfront, adding a late-stage drug in the challenging MDM2 inhibitor class.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.